Yibo Gao

6.7k total citations · 2 hit papers
142 papers, 3.4k citations indexed

About

Yibo Gao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yibo Gao has authored 142 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 44 papers in Oncology and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yibo Gao's work include RNA modifications and cancer (22 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Cancer-related molecular mechanisms research (14 papers). Yibo Gao is often cited by papers focused on RNA modifications and cancer (22 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Cancer-related molecular mechanisms research (14 papers). Yibo Gao collaborates with scholars based in China, United States and United Kingdom. Yibo Gao's co-authors include Jie He, Yannan Yang, Jiaming Xie, Fei Shao, Fengwei Tan, Zhaoli Chen, Wei Guo, Renda Li, Qi Xue and Xueying Yang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yibo Gao

126 papers receiving 3.3k citations

Hit Papers

Cuproptosis: mechanisms and links with cancers 2021 2026 2022 2024 2023 2021 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cuproptosis: mechanisms and links with cancers
    2023 479 citations Jiaming Xie, Yannan Yang et al. profile →
  2. Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis
    2021 160 citations Xiaoxiang Zhou, Kailun Fei et al. profile →

Peers

Yibo Gao
Shancheng Ren China
Peter J. Van Veldhuizen United States
Lin Zhao China
Cheng Zhan China
Tatjana Crnogorac‐Jurcevic United Kingdom
Jill Kolesar United States
Nithya Ramnath United States
Jennifer L. Spratlin Canada
Xiaoxiang Guan China
Fang Wang China
Shancheng Ren China
Yibo Gao
Citations per year, relative to Yibo Gao Yibo Gao (= 1×) peers Shancheng Ren

Countries citing papers authored by Yibo Gao

Since Specialization
Citations

This map shows the geographic impact of Yibo Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibo Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibo Gao more than expected).

Fields of papers citing papers by Yibo Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibo Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibo Gao. The network helps show where Yibo Gao may publish in the future.

Co-authorship network of co-authors of Yibo Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Yibo Gao. A scholar is included among the top collaborators of Yibo Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibo Gao. Yibo Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gao, Yibo, Jiaming Xie, Yannan Yang, Xiaoxiang Zhou, & Jie He. (2025). Induction of cuproptosis enhances sensitivity and overcomes resistance to osimertinib in lung cancer. Signal Transduction and Targeted Therapy. 10(1). 390–390.
3.
Gao, Yibo, Yi Li, Ling Huang, et al.. (2024). Identification of the effects of low temperature on grain-setting rate of different types of late-season rice (Oryza sativa) during heading. Field Crops Research. 318. 109584–109584. 4 indexed citations
4.
Tian, He, Junhui Yang, Ying Chen, et al.. (2024). Integrated molecular characterization reveals the pathogenesis and therapeutic strategies of pulmonary blastoma. SHILAP Revista de lepidopterología. 5(1). 82–92.
5.
Zhang, Lin, et al.. (2024). Squalene Epoxidase: Its Regulations and Links with Cancers. International Journal of Molecular Sciences. 25(7). 3874–3874. 10 indexed citations
6.
7.
Yang, Yafei, Jin Yang, Yongchang Lai, et al.. (2023). METTL3‐dependent m6A modification mediates bladder remodeling after partial bladder outlet obstruction through CCN2 activation. Neurourology and Urodynamics. 42(7). 1506–1521.
8.
Zhang, Tingbin, et al.. (2023). Climate Change and Anthropogenic Activity Co-Driven Vegetation Coverage Increase in the Three-North Shelter Forest Region of China. Remote Sensing. 15(6). 1509–1509. 13 indexed citations
9.
Liu, Fei, Zixian Wang, Xiaofan Li, et al.. (2022). Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors. Cancer Communications. 43(2). 214–224. 9 indexed citations
10.
Wang, Juhong, Fei Shao, Yannan Yang, et al.. (2022). A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability. Cancer Communications. 42(10). 1008–1027. 45 indexed citations
11.
Cheng, Jung‐Chien, et al.. (2022). EGF promotes human trophoblast cell invasion by downregulating CTGF expression via PI3K/AKT signaling. Reproduction. 165(1). 113–122. 6 indexed citations
12.
Guo, Wei, Qilin Huai, Tiejun Liu, et al.. (2022). Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma. Translational Lung Cancer Research. 11(4). 572–587. 6 indexed citations
13.
Fang, Lanlan, Zhen Wang, Ze Wu, et al.. (2021). GDF-8 stimulates trophoblast cell invasion by inducing ALK5-SMAD2/3-mediated MMP2 expression. Reproduction. 162(5). 331–338. 13 indexed citations
14.
Sun, Sijin, Kailun Fei, Guochao Zhang, et al.. (2021). Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas. Frontiers in Genetics. 11. 617174–617174. 17 indexed citations
15.
Yuan, Ting, Xin Wang, Sijin Sun, et al.. (2021). Profiling of 520 Candidate Genes in 50 Surgically Treated Chinese Small Cell Lung Cancer Patients. Frontiers in Oncology. 11. 644434–644434. 9 indexed citations
16.
17.
Shao, Fei, Xueli Bian, Hongfei Jiang, et al.. (2020). Association of phosphoenolpyruvate carboxykinase 1 protein kinase activity-dependent sterol regulatory element-binding protein 1 activation with prognosis of oesophageal carcinoma. European Journal of Cancer. 142. 123–131. 16 indexed citations
18.
19.
Tang, Shihuan, et al.. (2015). A Modularity-Based Method Reveals Mixed Modules from Chemical-Gene Heterogeneous Network. PLoS ONE. 10(4). e0125585–e0125585. 4 indexed citations
20.
Dai, Wen, Jianxin Chen, Peng Lu, et al.. (2012). Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula. Molecular BioSystems. 9(3). 375–385. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shancheng Ren Breakdown of academic impact, for papers by Peter J. Van Veldhuizen Breakdown of academic impact, for papers by Lin Zhao Breakdown of academic impact, for papers by Cheng Zhan Breakdown of academic impact, for papers by Tatjana Crnogorac‐Jurcevic Breakdown of academic impact, for papers by Jill Kolesar Breakdown of academic impact, for papers by Nithya Ramnath Breakdown of academic impact, for papers by Jennifer L. Spratlin Breakdown of academic impact, for papers by Xiaoxiang Guan Breakdown of academic impact, for papers by Fang Wang
Rankless by CCL
2026